---
figid: PMC7784492__MCS005629Xu_F3
figtitle: Pathways affected by mutations
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7784492
filename: MCS005629Xu_F3.jpg
figlink: pmc/articles/PMC7784492/figure/MCS005629XUF3/
number: F3
caption: Pathways affected by mutations. DNA-based analysis from solid tumors revealed
  multiple somatic mutations in the PI3K–Akt signaling pathway (PIK3CA, PIK3R1, PTEN,
  MTOR) across all samples. Other mutations were detected in both solid and liquid
  samples, affecting RAS–RAF, cell cycle, and other critical pathways regulating apoptosis
  and cell proliferation. Germline variant FGFR4 p.G388R was detected. It creates
  an additional binding site for STAT3 at the cell membrane so it can be phosphorylated
  without upstream signals from preclinical studies. If the above conclusion holds
  true in this patient, the activated STAT3 might have established a resistance mechanism
  for treatment targeting the PI3K-mTOR pathway.
papertitle: 'Case report: 16-yr life history and genomic evolution of an ER+ HER2−
  breast cancer.'
reftext: Bing Xu, et al. Cold Spring Harb Mol Case Stud. 2020 Dec;6(6):a005629.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9707363
figid_alias: PMC7784492__F3
figtype: Figure
redirect_from: /figures/PMC7784492__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7784492__MCS005629Xu_F3.html
  '@type': Dataset
  description: Pathways affected by mutations. DNA-based analysis from solid tumors
    revealed multiple somatic mutations in the PI3K–Akt signaling pathway (PIK3CA,
    PIK3R1, PTEN, MTOR) across all samples. Other mutations were detected in both
    solid and liquid samples, affecting RAS–RAF, cell cycle, and other critical pathways
    regulating apoptosis and cell proliferation. Germline variant FGFR4 p.G388R was
    detected. It creates an additional binding site for STAT3 at the cell membrane
    so it can be phosphorylated without upstream signals from preclinical studies.
    If the above conclusion holds true in this patient, the activated STAT3 might
    have established a resistance mechanism for treatment targeting the PI3K-mTOR
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Myb
  - Pi3K21B
  - Taf5
  - l(1)G0020
  - Taf4
  - Pi3K92E
  - Rpn2
  - Sap-r
  - Akt
  - Nf1
  - Pi3K59F
  - Pi3K68D
  - Pten
  - Raf
  - Crtc
  - rl
  - p38a
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - DCTN6-p27
  - dap
  - CG9588
  - LanB2
  - anon-70Db
  - CycE
  - Cdk2
  - CycD
  - Cdk4
  - ebi
  - E2f2
  - E2f1
  - rb
  - FGFR4
  - KRAS
  - HRAS
  - NRAS
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - AKT1
  - AKT2
  - AKT3
  - NF1
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PTEN
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RPTOR
  - MAP2K1
  - MAP2K2
  - STAT3
  - MAPK3
  - MAPK1
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CCNE1
  - CCNE2
  - CDK2
  - CCND1
  - CCND2
  - CCND3
  - CDK4
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
---
